Zack Abbott
Zack Abbott is the founder and CEO of ZBiotics, the company that brought the world's first genetically engineered probiotics to market. After completing his PhD in Microbiology and Immunology at the University of Michigan, he focused on engineering probiotic bacteria that could help solve everyday problems of human health. ZBiotics's mission is to make GMOs people love by building totally novel products with unique and beneficial functions, and then being transparent with consumers that genetic engineering was used to build those products that have the benefits they want. ZBiotics is working to build a future where people can be excited about the use of genetic engineering, and that starts with responsibility, transparency, and people-first benefits.
ZBiotics
Beyond Compliance: Leveraging Quality as a Differentiator to Inspire Trust and Drive Success
-
In biotech, we have the opportunity to leverage quality for more than just meeting regulations—we can use quality testing and controls to build trust, credibility, and a lasting competitive edge. Holding GMO products to the highest standards and communicating those standards can shift public perception, drive consumer confidence, and create new opportunities for innovation. With rigorous testing and a clear communication plan, prioritizing quality transforms not just our products, but the industry as a whole.
Bridging the Gap Between Biotech Innovation and Consumer Acceptance
-
The potential to revolutionize consumer products with biotechnology is inevitable. However, the path from lab innovation to widespread consumer adoption requires education and communication. This panel explores the critical gap between cutting-edge biotech developments and consumer acceptance, focusing on strategies to build trust, address concerns, and effectively communicate the benefits of bio-based products. In 2030, what will we say we spoke about in 2025?
Beyond the Butterfly: Building a Trust Mark for Responsible GMOs
-
The "Non-GMO" butterfly label treats all GMOs as inherently risky, framing them as purely good or bad. In reality, genetic engineering is a tool that can be used responsibly or irresponsibly. To build trust, the biotech community could create its own certification—one that ensures GMO innovation is safe, beneficial, and transparent. This workshop will explore how to develop a trust mark, like B Corp or LEED for biotech, that signals quality, ethics, and sustainability. Together, we’ll define key criteria, discuss its potential impact on public trust, and explore how SynBio and biotech can lead this movement.
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495
